Goat Anti-Horse IgG(T) Polyclonal Antibody, Unconjugated from Bethyl Laboratories
Rabbit Anti-Human Protein Kinase-A (PKA) Regulatory subunit IIB Antibody, Unconjugated from CEDARLANE Laboratories Limited
Goat Anti-Human STMN2 Polyclonal Antibody, Unconjugated from Abcam
...ember of the paired box (PAX) family of transcript...ontain a paired box domain and a paired-type homeo...fetal development. Mutations in paired box gene 3 ...cial-deafness-hand syndrome, and alveolar rhabdomy...
Biology Products:...nking water during a long-distance race may do ser... you,re drinking too much, according to a cardiolo...or any long-distance athletes who drink too much w...y for developing hyponatremia, a condition marked ...sult in physical symptoms such as lethargy, disori...
...nking water during a long-distance race may do ser... you,re drinking too much, according to a cardiolo...or any long-distance athletes who drink too much w...y for developing hyponatremia, a condition marked ...sult in physical symptoms such as lethargy, disori...
...ryonic stem cells with identical genomes grow into...in. At one time, scientists believed the differenc...es switched on inside developing cells. Then, stud...ein that permanently turns off neuronal genes in t...hat precursor nerve cells contain that same repres...
Other Biology News:Bush, Cheney and Rumsfeld are now species of slime-mold beetles -- but strictly in homage 2Too much water may be as dangerous as too little during long-distance athletic events 2Gene keeps neural cells on correct developmental path 2Gene keeps neural cells on correct developmental path 3(Date:12/2/2009)NEW YORK, Dec. 2 Reportlinker.com announces that a new market research report is available in its catalogue: ,, Carbondioxide Incubators - A Global Market Perspective ,, http://www.reportlinker.co
(Date:12/2/2009)NEW YORK, Dec. 2 Nearly 600 medical research executives, scientists, policy makers, and funders today convened to explore novel development approaches and innovative funding strategies at the inaugur
(Date:12/2/2009)TUSTIN, Calif., Dec. 2 Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ) today reported completion of patient enrollment in a dose confirmation and dosimetry trial of Cotara® in patients with rel
(Date:12/2/2009)LIBREVILLE, Gabon, December 2 , - "Bolstering Biodiversity in Africa: Everyone,s Problem and Heritage" , Coinciding with the International Year of Biodiversity, 2-3 June 2010 the,Gabonese Rep
Breaking Biology Technology:Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4Medical Research Leaders Explore Novel Strategies to Expedite the Search for Cures 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5Libreville International Conference 2-3 June 2010 2